Skip to content

Dermira, Inc.

Delisted

CIK 1557883fmd_1CQ38W52112TYGXKGSRVV2FMBAManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2019, 28 periods

Latest annual · FY2018

Millions
Total revenues
42
Gross profit
41
Operating income
(214)
Net income
(222)
Free cash flow
(214)

Latest quarter · Q3 FY2019

Millions
Total revenues
12
Gross profit
10
Operating income
(55)
Net income
(58)
Free cash flow
(6)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
+79.7%
Revenue, 5 yearsFY2013 to FY2018
n/m
Net income, 5 yearsFY2013 to FY2018
n/m

Dermira, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$42.3 million$4.5 million+832.4%10-K 2019-02-26 · proof
Gross profit$41.2 million10-K 2019-02-26 · proof
Operating income-$214 million-$300.3 million10-K 2019-02-26 · proof
Net income-$221.5 million-$303.3 million10-K 2019-02-26 · proof
Cash from operating activities-$213.1 million-$104 million10-K 2019-02-26 · proof
Free cash flow-$213.7 million-$104.2 million10-K 2019-02-26 · proof
Total assets$344.3 million$560.8 million-38.6%10-K 2019-02-26 · proof
Total liabilities$353.4 million$411.1 million-14.1%10-K 2019-02-26 · proof
Cash and cash equivalents$105 million$295.9 million-64.5%10-K 2019-02-26 · proof
What was Dermira, Inc.'s revenue in fiscal 2018?
Dermira, Inc. reported revenue of $42.3 million for fiscal 2018 (the year ended Dec 31, 2018), against $4.5 million the year before (+832.4%). Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What was Dermira, Inc.'s gross profit in fiscal 2018?
Dermira, Inc. reported gross profit of $41.2 million for fiscal 2018 (the year ended Dec 31, 2018). Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What was Dermira, Inc.'s operating income in fiscal 2018?
Dermira, Inc. reported operating income of -$214 million for fiscal 2018 (the year ended Dec 31, 2018), against -$300.3 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What was Dermira, Inc.'s net income in fiscal 2018?
Dermira, Inc. reported net income of -$221.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$303.3 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What was Dermira, Inc.'s cash from operating activities in fiscal 2018?
Dermira, Inc. reported cash from operating activities of -$213.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$104 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What was Dermira, Inc.'s free cash flow in fiscal 2018?
Dermira, Inc. reported free cash flow of -$213.7 million for fiscal 2018 (the year ended Dec 31, 2018), against -$104.2 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What are Dermira, Inc.'s total assets?
As of Dec 31, 2018, Dermira, Inc. reported total assets of $344.3 million, against $560.8 million a year earlier (-38.6%). Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What are Dermira, Inc.'s total liabilities?
As of Dec 31, 2018, Dermira, Inc. reported total liabilities of $353.4 million, against $411.1 million a year earlier (-14.1%). Source: the 10-K filed with the SEC on Feb 26, 2019. SEC
What are Dermira, Inc.'s cash and cash equivalents?
As of Dec 31, 2018, Dermira, Inc. reported cash and cash equivalents of $105 million, against $295.9 million a year earlier (-64.5%). Source: the 10-K filed with the SEC on Feb 26, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1557883&period_type=annual&limit=5"

Information only, not investment advice.